Sogulasvhili, T. et al. (2026) “Colchicine Plus Rosuvastatin/Ezetimibe for Residual Cardiovascular Risk: Mechanistic Rationale, Safety Concerns and Research Priorities”, Georgian Biomedical and Medical Nexus, 4(3), pp. 177–186. doi:10.52340/GBMN.2026.01.01.180.